loader

Disclaimer

The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above
Close

Search

See all results for ""
bharat-anand

Bharat Anand

, New Delhi

Partner | Mergers and Acquisitions, Private Equity, Corporate and Commercial

education

  • Solicitor, England & Wales (2008)
  • B.A. (Law), Jesus College, Cambridge University (1999)
  • B.A. (Hons.) Economics, Hans Raj College, Delhi University (1998)

Bharat Anand is a Partner in the Corporate and Commercial practice group and leads the Firm’s NCR Delhi office and is also a member of the Firm’s National Executive Committee.  

He specialises in advising clients on mergers and acquisitions, joint ventures, private equity transactions as well as being a strategic advisor on particularly complex or sensitive situations in India. He has a wide range of industry experience including financial services, insurance, renewable energy, telecom, information technology, manufacturing and consumer goods. He represents financial sponsors, founders and family offices on control deals, growth capital investments, joint ventures and exits. He has also advised Indian and foreign clients on disputes in India.

Bharat is ranked by both Chambers Asia Pacific and UK as a “Band 1 Lawyer” for M&A work and is recognised as a Global Leader by “Who’s Who Legal” for M&A and Governance issues. He has also served as a member of the National Executive Committee of FICCI.

Bharat read law at Jesus College, Cambridge and is an alumnus of St. Columba’s School. He is a dual qualified lawyer (India and England Wales). Prior to joining the Firm in 2009, Bharat had a successful career at Freshfields (London) for several years as a corporate and M&A lawyer.

Professional Affiliations

  • Bar Council of Delhi
  • Law Society of England and Wales, U.K.
  • Fellow, Cambridge Commonwealth Society, U.K.

Recognition and Accomplishments

  • Bharat is ranked by both Chambers Asia Pacific and UK as a “Band 1 Lawyer” for M&A work in Delhi
  • Bharat is recognised by Who’s Who Legal (M&A and Governance) for his strong expertise in complex M&A transactions

Representative Matters

Bharat Anand has represented and advised the following clients

Mankind Pharma

Advised on the recent investment by ChrysCapital.

CK Birla Group

Advised in connection with its JV with Peugeot and transfer of Ambassador brand.

Bandhan Bank

Advised in connection with IFC’s and GIC’s investment and reorganization of Bandhan’s microfinance business.

Fosun

Advised in connection with its investment in Delhivery Pvt Ltd.

Prosegur Compania De Seguridad S.A.

Advised in connection with the sale of its stake in its Alarm Monitoring and Response Services JV.

Airbus Industries

Advised in connection with various matters in India.

Daher Capital

Advised in connection with its first direct VC investment in India in Workcell Solutions Private Limited.

Blackstone

Advised on various matters in India including its proposed investment in a bottling company in North India.

L N Bangur Group

Advised in relation to sale of 53.46% stake in Andhra Paper Mills to International Paper Company.

Publications

iconArticle

03 Jul '23
Lexology GTDT - Public M&A

iconArticle

06 Jul '21
Public M&A

iconArticle

15 Feb '21
Budget 2021: Future-proofing India’s growth

iconArticle

11 Sep '20
Public M&A 2020

iconExternal Links

12 May '20
SEBI's COVID19 pill for Stressed Companies - Respite or Conundrum?

Similar profiles